SCHEMBL8098846

SCHEMBL8098846

CC(C)(C)OC(=O)N1CCC(n2cc(-c3cccc(F)c3)c3c(N)ncnc32)CC1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 18/20 0.75
EGFR P00533 12/20 0.75
ABL1 P00519 11/20 0.75
ABL2 P42684 11/20 0.75
RIPK2 O43353 1/20 0.64
LCK P06239 4/20 0.56
MEN1 O00255 1/20 0.55
JAK2 O60674 1/20 0.54
NTRK1 P04629 1/20 0.54
INSR P06213 1/20 0.54
NPM1 P06748 1/20 0.54
CSF1R P07333 1/20 0.54
LYN P07948 1/20 0.54
RET P07949 1/20 0.54
IGF1R P08069 1/20 0.54
MET P08581 1/20 0.54
ROS1 P08922 1/20 0.54
PDGFRB P09619 1/20 0.54
KIT P10721 1/20 0.54
BCR P11274 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8098935 0.91 SRC (0.90) SRCEGFRABL1ABL2LCK
SCHEMBL8098919 0.89 SRC (0.90) SRCEGFRABL1ABL2RIPK2
SCHEMBL8108104 0.89 SRC (0.91) SRCEGFRABL1ABL2LCK
SCHEMBL7016480 0.88 RIPK2 (0.62) SRCEGFRABL1ABL2RIPK2
SCHEMBL27379837 0.87 RIPK2 (0.65) SRCEGFRABL1ABL2RIPK2
SCHEMBL28667953 0.86 SRC (0.79) SRCEGFRABL1ABL2RIPK2
SCHEMBL29503488 0.85 SRC (0.66) SRCEGFRABL1ABL2RIPK2
SCHEMBL21084200 0.85 SRC (0.66) SRCEGFRABL1ABL2RIPK2
SCHEMBL15708998 0.85 SRC (0.75) SRCEGFRABL1ABL2LCK
SCHEMBL15708999 0.85 SRC (0.75) SRCEGFRABL1ABL2LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6051577-A TYROSINE INHIBITORS; BONE DISORDERS NOVARTIS AG (CH) 2000-04-18 US disclosed